跳至主要内容
临床试验/NCT03118479
NCT03118479终止1 期

Effect of Varying Testosterone Levels on Insulin Sensitivity in Men With Idiopathic Hypogonadotropic Hypogonadism

Massachusetts General Hospital1 个研究点 分布在 1 个国家目标入组 7 人开始时间: 2010年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
终止
入组人数
7
试验地点
1
主要终点
Change in glucose tolerance

研究概览

简要总结

The investigators are doing this research study to look at the relationship between testosterone (the main sex hormone in men) and insulin (the hormone that controls blood sugar levels) in men with Idiopathic Hypogonadotropic Hypogonadism (IHH).

The investigators hypothesize that normalizing testosterone levels in men with IHH enhances insulin sensitivity, reduces visceral fat, increases lean body mass, and improves the lipid profile.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Diagnosis of idiopathic hypogonadotropic hypogonadism or Kallmann Syndrome
  • mean testosterone level less than 300 ng/dl
  • stable weight for the previous 3 months (no weight change greater than or equal to 10 lbs)
  • normal serum TSH
  • normal serum prolactin levels

排除标准

  • Type 2 diabetes mellitus
  • history of diabetes in parents
  • sleep apnea
  • bleeding disorder
  • seeking fertility
  • 2 or more cardiovascular risk factors: smoking, hypertension, diabetes, dyslipidemias, family history of cardiovascular disease before age
  • history of previous cardiovascular event: myocardial infarction, unstable angina, cerebro-vascular accident.
  • illicit drug use/alcohol use (>4 drinks per day)

研究组 & 干预措施

Androgen only addback

Experimental

Anastrozole 10 mg orally once daily for 3 months Testosterone gel 7.5 g transdermally daily for 3 months.

干预措施: Anastrozole Pill (Drug)

Androgen only addback

Experimental

Anastrozole 10 mg orally once daily for 3 months Testosterone gel 7.5 g transdermally daily for 3 months.

干预措施: Testosterone (Drug)

Combined sex steroid addback

Experimental

Placebo (sugar pill) tablet once daily for 3 months Testosterone gel 7.5 g transdermally daily for 3 months.

干预措施: Testosterone (Drug)

Combined sex steroid addback

Experimental

Placebo (sugar pill) tablet once daily for 3 months Testosterone gel 7.5 g transdermally daily for 3 months.

干预措施: Placebo Oral Tablet (Drug)

结局指标

主要结局

Change in glucose tolerance

时间窗: Change between baseline and 3 months

Response to 75 g glucose load

Change in insulin sensitivity

时间窗: Change between baseline and 3 months

IV glucose tolerance test

次要结局

  • Change in visceral fat(Change between baseline and 3 months)
  • Change in resting energy expenditure(Change between baseline and 3 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Frances Hayes

Associate Professor

Massachusetts General Hospital

研究点 (1)

Loading locations...

相似试验